The Rainwater Charitable Foundation, Aging Mind Foundation, Alzheimer’s Association, and [...]

Lungpacer Medical has received CMS New Technology Add-on Payment approval [...]

Nasus Pharma Ltd., a clinical-stage pharmaceutical company focused on developing [...]

FoRx Therapeutics has initiated a first-in-human clinical trial of FORX-428, [...]

Newron Pharmaceuticals has highlighted new preclinical findings published in Neuropsychopharmacology [...]

InflaRx has reported its Q2 2025 results and provided updates [...]

10x Genomics has agreed to acquire Scale Biosciences, a specialist [...]

New research from Pioneer Group, in collaboration with Beauhurst, reveals [...]

Boston-based Strand Therapeutics has raised $153 million in a Series [...]

DEBRA Research, a non-profit focused on Epidermolysis bullosa (EB), has [...]